Kevin Lundquist

CFO

Equibles does not estimate personal net worth.

Get an email with a short summary when Outlook Therapeutics, Inc. publishes a filing, an earnings call transcript or a press release.

Get OTLK alerts

About Kevin Lundquist

Kevin Lundquist is recorded as CFO at Outlook Therapeutics, Inc. (OTLK) since September 1, 2026. Outlook Therapeutics, Inc. reported in an 8-K filed August 27, 2026 that Kevin Lundquist was appointed Chief Financial Officer, Treasurer, principal financial officer and principal accounting officer, effective September 1, 2026. Outlook Therapeutics, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Outlook Therapeutics, Inc. includes Robert C. Jahr (CEO and Board Member), Robert Charles Jahr (CEO and Board Member), Faisal G. Sukhtian (Chairman) and 7 others.

“on August 27, 2026, the Board appointed Kevin Lundquist as the Company’s Chief Financial Officer, Treasurer, principal financial officer and principal accounting officer, effective as of the Transition Date.”

Outlook Therapeutics, Inc. Form 8-K, filed August 27, 2026 · Read the filing

Affiliation history

Outlook Therapeutics, Inc. (OTLK)
CFO

SEC 8-K

Current
2026-09-01–present

Company network

Outlook Therapeutics, Inc.

OTLK

Current role

Biotechnology · Healthcare

CFO

2026-09-01–present

Leadership on record at Outlook Therapeutics, Inc.

Robert C. Jahr CEO, Board Member
Robert Charles Jahr CEO, Board Member
Faisal G. Sukhtian Chairman
Lawrence Kenyon CFO, Board Member
LawrenceA. Kenyon CFO
Terry Dagnon COO
Andong Huang Board Member
Dr. Julia A. Haller Board Member
Gerd Auffarth Board Member
Julia A. Haller Board Member

Recent activity

Executive change Appointed: Chief Financial Officer, Treasurer, principal financial officer and principal accounting officer Outlook Therapeutics, Inc. (OTLK)
2026-09-01